BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30659395)

  • 21. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.
    Aoude LG; Vajdic CM; Kricker A; Armstrong B; Hayward NK
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):278-9. PubMed ID: 23171164
    [No Abstract]   [Full Text] [Related]  

  • 22. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure.
    Matichard E; Verpillat P; Meziani R; Gérard B; Descamps V; Legroux E; Burnouf M; Bertrand G; Bouscarat F; Archimbaud A; Picard C; Ollivaud L; Basset-Seguin N; Kerob D; Lanternier G; Lebbe C; Crickx B; Grandchamp B; Soufir N
    J Med Genet; 2004 Feb; 41(2):e13. PubMed ID: 14757863
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
    Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
    Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
    Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    Kocarnik JM; Park SL; Han J; Dumitrescu L; Cheng I; Wilkens LR; Schumacher FR; Kolonel L; Carlson CS; Crawford DC; Goodloe RJ; Dilks H; Baker P; Richardson D; Ambite JL; Song F; Quresh AA; Zhang M; Duggan D; Hutter C; Hindorff LA; Bush WS; Kooperberg C; Le Marchand L; Peters U
    J Invest Dermatol; 2014 Jul; 134(7):2049-2052. PubMed ID: 24480881
    [No Abstract]   [Full Text] [Related]  

  • 26. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
    Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
    Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic predisposition to melanoma.
    Hawkes JE; Truong A; Meyer LJ
    Semin Oncol; 2016 Oct; 43(5):591-597. PubMed ID: 27899192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes.
    De Simone P; Bottillo I; Valiante M; Iorio A; De Bernardo C; Majore S; D'Angelantonio D; Valentini T; Sperduti I; Piemonte P; Eibenschutz L; Ferrari A; Carbone A; Buccini P; Paiardini A; Silipo V; Frascione P; Grammatico P
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma genetics: an update on risk-associated genes.
    Udayakumar D; Tsao H
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):415-29, vii. PubMed ID: 19464594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
    Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
    Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
    Bergman W; Gruis NA
    Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
    [No Abstract]   [Full Text] [Related]  

  • 33. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Roberts MR; Asgari MM; Toland AE
    Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plenty new under the sun.
    Rees J
    J Invest Dermatol; 2006 Aug; 126(8):1691-2. PubMed ID: 16845407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
    Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
    Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
    Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
    Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.
    Thomas NE; Kanetsky PA; Edmiston SN; Alexander A; Begg CB; Groben PA; Hao H; Busam K; Ollila DW; Berwick M; Conway K
    J Invest Dermatol; 2010 May; 130(5):1463-5. PubMed ID: 20043015
    [No Abstract]   [Full Text] [Related]  

  • 39. Hereditary uveal melanoma: a report of a germline mutation in BAP1.
    Höiom V; Edsgärd D; Helgadottir H; Eriksson H; All-Ericsson C; Tuominen R; Ivanova I; Lundeberg J; Emanuelsson O; Hansson J
    Genes Chromosomes Cancer; 2013 Apr; 52(4):378-84. PubMed ID: 23341325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.